Twitter | Pretraživanje | |
I Am Biotech
I Am Biotech is where biotech professionals and enthusiasts can come together and discuss the promise of biotech innovation.
31.540
Tweetovi
6.198
Pratim
91.002
Osobe koje vas prate
Tweetovi
I Am Biotech 3 h
First childhood helps explain why virus hits some people harder than others
Reply Retweet Označi sa "sviđa mi se"
I Am Biotech 6 h
Coming soon at : Speaker Dr. Benjamin Cowen, of ImmunoMet, a clinical-stage company developing anti-tumor and immune-metabolism therapies. Here's an early look:
Reply Retweet Označi sa "sviđa mi se"
I Am Biotech 9 h
". . . the international reference pricing is “not the right way” to lower prescription drugs costs and calls on the president to ensure America continues to lead the world in biomedical innovation," says Rachel King, co-founder and CEO of GlycoMimetics:
Reply Retweet Označi sa "sviđa mi se"
I Am Biotech 11 h
BIG NEWS: BIO World Congress Is Now BIO IMPACT -- here's the full story:
Reply Retweet Označi sa "sviđa mi se"
I Am Biotech 14 h
Sign up for the BIO Boardlist to support our mission of promoting workforce development, , and at
Reply Retweet Označi sa "sviđa mi se"
I Am Biotech 5. velj
can help us win in the fight against and America’s biopharmaceutical companies are leading the charge.
Reply Retweet Označi sa "sviđa mi se"
I Am Biotech 5. velj
Despite the rhetoric from politicians in Washington, national data shows retail drug costs are NOT skyrocketing – just look at ’s own data:
Reply Retweet Označi sa "sviđa mi se"
I Am Biotech 5. velj
Adopting foreign price controls “prevents investors from being able to invest, and inventors from being able to invent.” Our full statement:
Reply Retweet Označi sa "sviđa mi se"
I Am Biotech 4. velj
The Message We Hope President Trump Will Convey During His State of the Union Address from
Reply Retweet Označi sa "sviđa mi se"
I Am Biotech 4. velj
Meet ImmunoMet’s Dr. Benjamin Cowen, Speaker at
Reply Retweet Označi sa "sviđa mi se"
I Am Biotech 4. velj
Download your copy of BIO’s first annual report on and in at
Reply Retweet Označi sa "sviđa mi se"
I Am Biotech 4. velj
On —instead of celebrating new treatments, policymakers continue to promote controls that would harm future cures. VIDEO: how an international price index would have an “absolutely chilling” effect on investments in risky cures.
Reply Retweet Označi sa "sviđa mi se"
I Am Biotech 4. velj
For nearly 2 decades, the BIO World Congress has been a catalyst for the growth of the biobased economy. But to better represent the influence biotech innovation has across sectors, today we are unveiling a new name: BIO IMPACT Ag & Environment Conference.
Reply Retweet Označi sa "sviđa mi se"
I Am Biotech 4. velj
Find out the 4 key ways is helping achieve the UN Development Goals:
Reply Retweet Označi sa "sviđa mi se"
I Am Biotech 4. velj
Reply Retweet Označi sa "sviđa mi se"
I Am Biotech 4. velj
is a Shared Goal; Should be a Shared Solution
Reply Retweet Označi sa "sviđa mi se"
I Am Biotech 4. velj
Antibody Screening Technology Is Never Out of Sorts
Reply Retweet Označi sa "sviđa mi se"
I Am Biotech 3. velj
ICYMI: WHO declares Wuhan 2019-nCoV a global health emergency
Reply Retweet Označi sa "sviđa mi se"
I Am Biotech 3. velj
Proxy firms have outsized market influence, and their opaque standards, one-size-fits-all recommendations, and conflicts of interest negatively impact emerging biotech companies. Read BIO’s comment letter to the SEC on improving proxy firm transparency.
Reply Retweet Označi sa "sviđa mi se"
I Am Biotech 3. velj
In the UK, £20m announced to fund for and other infectious diseases
Reply Retweet Označi sa "sviđa mi se"